Login to Your Account



DEALS AND M&A NEWS

SHANGHAI – Innovent Biologics Inc., an antibody-focused company based in Suzhou, is betting that the best things will come in pairs.

Mesoblast Ltd. lost more than a third of its market value Tuesday as Teva Pharmaceutical Industries Ltd. returned full development and commercialization rights to its advanced chronic heart failure therapy, MPC-150-IM.

SHANGHAI – Shenyang Sunshine Pharmaceutical Co. Ltd. (3SBio), a revenue-generating biotech with products in China, has decided to try its hand at the hottest category in immuno-oncology.

More DEALS AND M&A Headlines

Cast Your Vote

Should there be restrictions on the use of gene-editing technology?: